Urethral bulking agent injections are used to treat urinary incontinence, the accidental leakage of urine. During this procedure, a bulking agent such as silicon is injected into the wall of the ...

Current evidence on the safety and short-term efficacy of intramural urethral bulking procedures for stress urinary incontinence is adequate to support the use of these procedures provided that normal ...

Bulkamid® Urethral Bulking System is indicated for urethral injection for the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD) in adult women who have SUI or ...

NEW YORK, Aug. 19, 2021 /PRNewswire/ -- The Europe urethral bulking systems market was valued US$ 21.2 Mn in 2020, and is expected to accelerate at a decent CAGR of approximately 6% over the forecast ...

An estimated 15 million women in the U.S. deal with stress urinary incontinence, an accidental leak of urine after pressure on the bladder from movement, a cough or a sneeze. A new procedure being ...

December 4, 2006 -- The US Food and Drug Administration (FDA) has approved a urethral bulking agent for the treatment of stress urinary incontinence in women; a propylene mesh urethral sling for the ...

Urinary incontinence is the leakage of urine due to loss of bladder control. The condition is common, impacting up to 50 percent of women. While urinary incontinence occurs more often in older women, ...

NICE has produced information for the public on this procedure. It explains the nature of the procedure and the guidance issued by NICE, and has been written with patient consent in mind.